Teva (TEVA) to resume Lotrel sale after US ruling. Novartis counters by planning its own generic offering. Read IsraelNewsletter’s analysis of Teva’s win.

Haaretz with the scoop that Tower Semi (TSEM) is in advanced negotiations to sell their semiconductors to two large Chinese companies. Each win is expected to be worth multiple millions of dollars a year.

ECtel (ECTX) announced that a leading telecom operator in Russia has placed a first-time order for ECtel’s FraudView 8. ECtel’s CEO and President, Itzik Weinstein, was quoted as saying, “We see excellent opportunities in The Former Soviet Union region as demonstrated at this order as well as other recent orders.” See our recent coverage of ECTel as a leading fraud prevention service provider.

Companies reporting:

Comverse (CMVT.PK)

Verint (VRNT)

Ulticom (ULCM.PK)

Share with others:

Related posts

• No related posts.